Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Return on Assets: 2021-2023

Historic Return on Assets for Candel Therapeutics (CADL) over the last 2 years, with Sep 2023 value amounting to -0.67%.

  • Candel Therapeutics' Return on Assets fell 28.00% to -0.67% in Q3 2023 from the same period last year, while for Sep 2023 it was -0.67%, marking a year-over-year decrease of 28.00%. This contributed to the annual value of -0.42% for FY2022, which is 2.00% down from last year.
  • According to the latest figures from Q3 2023, Candel Therapeutics' Return on Assets is -0.67%, which was down 15.70% from -0.58% recorded in Q2 2023.
  • In the past 5 years, Candel Therapeutics' Return on Assets registered a high of -0.28% during Q4 2021, and its lowest value of -0.67% during Q3 2023.
  • Over the past 3 years, Candel Therapeutics' median Return on Assets value was -0.39% (recorded in 2022), while the average stood at -0.43%.
  • Data for Candel Therapeutics' Return on Assets shows a maximum YoY decreased of 28bps (in 2023) over the last 5 years.
  • Quarterly analysis of 3 years shows Candel Therapeutics' Return on Assets stood at -0.28% in 2021, then dropped by 15bps to -0.43% in 2022, then decreased by 28bps to -0.67% in 2023.
  • Its Return on Assets stands at -0.67% for Q3 2023, versus -0.58% for Q2 2023 and -0.49% for Q1 2023.